# De-tensioning Patch, in Subjects With Type 1 Diabetes and Lipohypertrophy

> **NCT06025513** · NA · COMPLETED · sponsor: **Neodyne Biosciences, Inc.** · enrollment: 29 (actual)

## Conditions studied

- Insulin Resistance
- Lipohypertrophy

## Interventions

- **DEVICE:** Embrace Patch

## Key facts

- **NCT ID:** NCT06025513
- **Lead sponsor:** Neodyne Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-16
- **Primary completion:** 2024-12-18
- **Final completion:** 2025-03-13
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06025513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06025513, "De-tensioning Patch, in Subjects With Type 1 Diabetes and Lipohypertrophy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06025513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*